amikacin has been researched along with Fetal Growth Restriction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bökenkamp, A; Delemarre-van de Waal, HA; Schreuder, MF; Timmermans, SM; van Wijk, JA; Wilhelm, AJ | 1 |
Allegaert, K; Anderson, BJ; de Zegher, F; van den Anker, JN; Vanhaesebrouck, S | 1 |
2 other study(ies) available for amikacin and Fetal Growth Restriction
Article | Year |
---|---|
Impact of gestational age and birth weight on amikacin clearance on day 1 of life.
Topics: Amikacin; Anti-Bacterial Agents; Birth Weight; Female; Fetal Growth Retardation; Gestational Age; Glomerular Filtration Rate; Humans; Infant, Newborn; Infant, Premature; Kidney; Kidney Function Tests; Male; Nephrons; Reproducibility of Results; Retrospective Studies | 2009 |
Renal drug clearance in preterm neonates: relation to prenatal growth.
Topics: Amikacin; Anti-Bacterial Agents; Drug Monitoring; Fetal Growth Retardation; Glomerular Filtration Rate; Humans; Infant, Newborn; Infant, Premature; Metabolic Clearance Rate; Vancomycin | 2007 |